A super-enhancer (large clusters of enhancers) in the MAGI2 gene is a driver of oncogenic phenotype in multiple myeloma and is further accentuated by binding the oncogenic MAF transcription factor [156]. The gene discussed is MAGI2; the disease is plasma cell myeloma.